Voluntary Recall: Levoxyl (Thyroid Treatment)
Monday, February 18, 2019
April 26, 2013, King Pharmaceuticals, a subsidiary of Pfizer, has voluntarily recalled Levoxyl. Because of the recall, Levoxyl is currently on backorder through mid 2014. Current inventory of this product has been depleted and no backorders are being accepted.
The voluntary recall is due to an odor that emits from bottles that have been opened. This odor is associated with 100- and 1000-tablet pharmacy bottles that are made up of an oxygen-absorbing material. According to Pfizer, the odor is not likely to cause any adverse health consequences and there is no need for patients to return or discard the medication they have. Patients may continue to take the medication in accordance with their health care provider’s prescribed directions.
Levoxyl is used in the treatment of hypothyroidism, certain types of goiters, thyroid cancer, and other thyroid disorders.
To help members work with their prescribers to find a suitable alternative to Levoxyl, Benecard has identified two alternatives to consider:
- Levothyroxine Sodium (Generic)
- Synthroid (Non-Preferred)
Please be aware that if the non-preferred medication is chosen, out of pocket expenses may increase.
If you have any questions about this recall please contact your local retail pharmacist or speak to your doctor.
Adverse events that may be related to the use of this product may also be reported to the United States Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:
Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail the form to: MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787Fax: 1-800-FDA-0178